Agios Pharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Agios Pharmaceuticals's balance sheet done over the years? Its assets were worth $937,118,000 last year, which is less than in the previous period. 13% of Agios Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $126,099,000, which means an decrease by -9% compared compared to last year.
Debt to Assets
| 2014 | 491904000 | 67.53M | 13.73% |
|---|---|---|---|
| 2015 | 420065000 | 74.94M | 17.84% |
| 2016 | 619094000 | 260.50M | 42.08% |
| 2017 | 614397000 | 238.89M | 38.88% |
| 2018 | 858457000 | 170.92M | 19.91% |
| 2019 | 890741000 | 250.21M | 28.09% |
| 2020 | 852952000 | 453.45M | 53.16% |
| 2021 | 1437736000 | 145.76M | 10.14% |
| 2022 | 1238718000 | 137.90M | 11.13% |
| 2023 | 937118000 | 126.09M | 13.46% |
AGIO Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 88.20M | 139.25M | 203.12M | 127.43M | 80.93M | 805.42M | 567.75M | 573.56M | 375.90M | 14.03M |
Short term investments | 688.72M | 643.86M | 816.89M | 445.49M | 483.94M | 514.8M | 321.21M | 380.56M | 245.23M | 328.03M |
Net receivables | 2.81M | 2.20M | 4.37M | 25.39M | 15.31M | 10.44M | 3.67M | 8.31M | 11.59M | 12.66M |
Inventory | 19.07M | 8.49M | 16.19M | 14.69M | 7.33M | 869K | -143.81M | -32.25M | -58.90M | 1 |
Other current assets | 35.02M | 38.95M | 11.81M | -73.95M | 24.17M | 17.16M | 17.65M | 10.26M | 8.72M | 4.81M |
Total current assets | 833.83M | 832.77M | 1.06B | 636.67M | 611.70M | 613.78M | 445.26M | 559.89M | 337.32M | 359.54M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 69.79M | 88.11M | 104.23M | 117.54M | 126.10M | 24.32M | 24.43M | 25.33M | 23.22M | 6.38M |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term investments | 29.43M | 313.87M | 266.37M | 97.60M | 152.92M | 220.11M | 143.81M | 32.25M | 58.90M | 125.38M |
Other non-current assets | 4.05M | 3.95M | 2.9M | 1.12M | -279.03M | 238K | 891K | 1.61M | 611K | 590K |
Total non-current assets | 103.28M | 405.94M | 373.50M | 216.27M | 279.03M | 244.67M | 169.13M | 59.20M | 82.73M | 132.35M |
Total assets | 937.11M | 1.23B | 1.43B | 852.95M | 890.74M | 858.45M | 614.39M | 619.09M | 420.06M | 491.90M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 0 | 0 | 0 | 10.93M | 92.51M | 163.64M | 190.21M | 24.36M | 35.68M |
Short term debt | 30.01M | 13.66M | 11.15M | 7.41M | 6.91M | -59.80M | 0 | -154.29M | 0 | 0 |
Total current liabilities | 67.95M | 62.62M | 59.82M | 94.39M | 92.88M | 93.50M | 94.94M | 88.43M | 52.88M | 61.08M |
| Non-current liabilities: | ||||||||||
Long term debt | 113.97M | 71.99M | 85.93M | 97.78M | 106.74M | 0 | 0 | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | -55.83M | 3.27M | 0 | 261.26M | 50.58M | 17.60M | 18.15M | 17.77M | 17.36M | 3.72M |
Total non-current liabilities | 58.14M | 75.27M | 85.93M | 359.05M | 157.32M | 77.41M | 143.95M | 172.07M | 22.05M | 6.44M |
Total liabilities | 126.09M | 137.90M | 145.76M | 453.45M | 250.21M | 170.92M | 238.89M | 260.50M | 74.94M | 67.53M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |